WEBULL
News
SCPS
0.0004
NaN%
--
Weekly Report: what happened at SCPS last week (0112-0116)?
Weekly Report · 8h ago
Weekly Report: what happened at SCPS last week (0105-0109)?
Weekly Report · 01/12 09:58
Weekly Report: what happened at SCPS last week (1229-0102)?
Weekly Report · 01/05 09:54
Weekly Report: what happened at SCPS last week (1222-1226)?
Weekly Report · 12/29/2025 09:54
Weekly Report: what happened at SCPS last week (1215-1219)?
Weekly Report · 12/22/2025 09:53
Weekly Report: what happened at SCPS last week (1208-1212)?
Weekly Report · 12/15/2025 09:59
Weekly Report: what happened at SCPS last week (1201-1205)?
Weekly Report · 12/08/2025 09:57
Weekly Report: what happened at SCPS last week (1124-1128)?
Weekly Report · 12/01/2025 09:54
Weekly Report: what happened at SCPS last week (1117-1121)?
Weekly Report · 11/24/2025 09:58
Weekly Report: what happened at SCPS last week (1110-1114)?
Weekly Report · 11/17/2025 09:58
Weekly Report: what happened at SCPS last week (1103-1107)?
Weekly Report · 11/10/2025 09:56
Weekly Report: what happened at SCPS last week (1027-1031)?
Weekly Report · 11/03/2025 09:56
Weekly Report: what happened at SCPS last week (1020-1024)?
Weekly Report · 10/27/2025 09:59
Weekly Report: what happened at SCPS last week (1013-1017)?
Weekly Report · 10/20/2025 09:56
Weekly Report: what happened at SCPS last week (1006-1010)?
Weekly Report · 10/13/2025 09:58
Weekly Report: what happened at SCPS last week (0929-1003)?
Weekly Report · 10/06/2025 09:56
Weekly Report: what happened at SCPS last week (0922-0926)?
Weekly Report · 09/29/2025 09:56
Weekly Report: what happened at SCPS last week (0915-0919)?
Weekly Report · 09/22/2025 09:56
Weekly Report: what happened at SCPS last week (0908-0912)?
Weekly Report · 09/15/2025 11:54
Weekly Report: what happened at SCPS last week (0901-0905)?
Weekly Report · 09/08/2025 11:56
More
Webull provides a variety of real-time SCPS stock news. You can receive the latest news about Scopus Biopharma Inc. through multiple platforms. This information may help you make smarter investment decisions.
About SCPS
Scopus BioPharma Inc. is a biopharmaceutical company. The Company is developing therapeutics targeting serious diseases with significant unmet medical needs. Its lead development programs are CO-sTiRNA and MRI-1867. Its CO-sTiRNA is a novel, targeted immuno-oncology gene therapy for the treatment of multiple cancers. CO-sTiRNA is a dual-action STAT3 inhibitor. STAT3 is a gene that drives tumor cell growth and anti-tumor immune suppression. CO-sTiRNA also stimulates TLR9 receptors to activate the body’s immune defense to recognize and kill cancer cells. It is also developing MRI-1867 for the treatment of SSc. SSc is a chronic, systemic autoimmune disease. MRI-1867, is a peripherally-restricted, dual-action cannabinoid-1, or CB1, receptor inverse agonist and inhibitor of inducible nitric oxide synthase, or iNOS.